Search

The article focuses on the people involved in generating drug interaction information for health professionals' use. The people involved include data generators, such as basic scientists who research on the molecular mechanisms of drug-drug interactions (DDIs), information analysts who read the papers generated by data generators and produce electronic databases of DDIs, and clinical decision support (CDS) producers who convert what the information analysts produce for clinicians' use.

The article focuses on the electronic prescribing program (e-prescribing) in the U.S. It states that the program involves the recruitment of some 1,200 doctors throughout the U.S. to shift from paper to electronic records. It is inferred that those physicians who will participate in the program will receive extra payments from Medicare for ordering prescriptions online and performing other activities electronically. According to a broad-based coalition, such a step could prevent adverse drug events over the next 10 years.

The article reports on the possible adverse health effects from low doses of bisphenol a (BPA), according to studies posted online by the journal "Reproductive Toxicology." One paper, released by 38 scientists, shows that BPA appears to leach from food packaging and other sources at a rate that could cause adverse health effects in laboratory animals. Another cites incidence of uterine and ovarian abnormalities when female mice were injected with BPA.

The article addresses the problems generated by the explosion of information and knowledge on drug-drug interactions. It states that most information on drug interactions, in the form of published papers and studies, are thrown into a pile and that individual health care professionals are left to sort for information they can use to reduce the risk of adverse drug interactions in their patients. It cites the failure to organize drug interaction information into usable knowledge.